Page last updated: 2024-10-27

gliclazide and Kidney Failure, Chronic

gliclazide has been researched along with Kidney Failure, Chronic in 7 studies

Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Raslan, IA1
McDonald, EG1
Lee, TC1
Lee, YH1
Lee, CJ1
Lee, HS1
Choe, EY1
Lee, BW1
Ahn, CW1
Cha, BS1
Lee, HC1
Balkau, B1
Kang, ES1
Oei, E1
Samad, N1
Visser, A1
Chowdhury, TA1
Fan, SL1
Wong, MG1
Perkovic, V1
Chalmers, J2
Woodward, M2
Li, Q2
Cooper, ME1
Hamet, P1
Harrap, S2
Heller, S1
MacMahon, S1
Mancia, G1
Marre, M2
Matthews, D1
Neal, B1
Poulter, N1
Rodgers, A1
Williams, B1
Zoungas, S2
Mohammedi, K1
Patel, A1
Shestakova, MV1
De Vigan, C1
Delporte, MP1
Thomas, M1
Perrault, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study[NCT00949286]8,494 participants (Actual)Observational2010-01-31Completed
ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925]Phase 311,140 participants (Actual)Interventional2001-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

2 trials available for gliclazide and Kidney Failure, Chronic

ArticleYear
Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.
    Diabetes care, 2016, Volume: 39, Issue:5

    Topics: Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Combin

2016
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes.
    Diabetes care, 2016, Volume: 39, Issue:12

    Topics: Aged; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diagnostic Techniques, Cardiovascular; Disea

2016

Other Studies

5 other studies available for gliclazide and Kidney Failure, Chronic

ArticleYear
Missed Opportunities for Deprescription: A Teachable Moment.
    JAMA internal medicine, 2017, 07-01, Volume: 177, Issue:7

    Topics: Aged, 80 and over; Deprescriptions; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combina

2017
Comparing kidney outcomes in type 2 diabetes treated with different sulphonylureas in real-life clinical practice.
    Diabetes & metabolism, 2015, Volume: 41, Issue:3

    Topics: Cohort Studies; Creatinine; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypoglycemic Agen

2015
Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Diabetic medicine : a journal of the British Diabetic Association, 2016, Volume: 33, Issue:9

    Topics: Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2;

2016
[Diabetes mellitus and chronic kideny disease: modern diagnostics and treatment].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 2012, Issue:1

    Topics: Albuminuria; Blood Glucose; Diabetic Nephropathies; Early Medical Intervention; Gliclazide; Glomerul

2012
[Hypoglycemic complications of oral drug therapy of diabetes mellitus. 21 cases].
    La Nouvelle presse medicale, 1976, Apr-03, Volume: 5, Issue:14

    Topics: Age Factors; Aged; Diabetes Mellitus; Diabetic Coma; Drug Interactions; Female; Gliclazide; Glyburid

1976